European Journal of Chemistry 2012, 3(3), 356-358 | doi: | Get rights and content

Issue cover


Anticancer activity studies of some cyclic benzimidazole derivatives

Ali El-Shekeil (1,*) , Abeer Omer Obeid (2) , Sama Al-Aghbari (3)

(1) Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen
(2) Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen
(3) Chemistry Department, Faculty of Science, Sana’a University, 2463, Sana’a, Yemen
(*) Corresponding Author

Received: 23 Apr 2012 | Accepted: 17 Jun 2012 | Published: 30 Sep 2012 | Issue Date: September 2012


New benzimidazole derivatives, namely, (N-(4-methoxyphenyl)methylene]-1H-benzimidazol-2-amine (2a), (N-(3,4-dimethoxyphenyl)methylene]-1H-benzimidazol-2-amine (2b), and (N-(3,4,5-trimethoxyphenyl)methylene]-1H-benzimidazol-2-amine (2c) were synthesized by reaction of a Schiff base with malononitrile in absolute ethanol. Structures of compounds have been confirmed by IR, 1H NMR and elemental analysis. Compounds 2a-c were screened for their in vitro anticancer potential using HeLa and PC3 cells. All compounds showed limited cytotoxicity except compound 2a that showed a moderate cytotoxic effect towards HeLa cells.



Our editors have decided to support scientists to publish their manuscripts in European Journal of Chemistry without any financial constraints.

1- The article processing fee will not be charged from the articles containing the single-crystal structure characterization or a DFT study between September 15, 2023 and October 31, 2023 (Voucher code: FALL2023).

2. A 50% discount will be applied to the article processing fee for submissions made between September 15, 2023 and October 31, 2023 by authors who have at least one publication in the European Journal of Chemistry (Voucher code: AUTHOR-3-2023).

3. Young writers will not be charged for the article processing fee between September 15, 2023 and October 31, 2023 (Voucher code: YOUNG2023).

European Journal of Chemistry


PC3 cells; Hela cells; Cytotoxicity; Anti-cancer activity; Benzimidazole derivatives; 4-Amino-2-(3,4,5-trimethoxyphenyl)benzo[4,5]imidazo[1,2-a]pyrimidine-3-carbonitrile

Full Text:

PDF    Open Access

DOI: 10.5155/eurjchem.3.3.356-358.621

Links for Article

| | | | | | |

| | | | | | |

| | | |

Related Articles

Article Metrics

icon graph This Abstract was viewed 2680 times | icon graph PDF Article downloaded 845 times

Funding information

Sana’a University, Sana’a, Yemen



[1]. Le‐Le Shang, Yun Feng, Xing‐Lian Gao, Zi‐Ren Chen, Yu Xia, Wei‐Wei Jin, Chen‐Jiang Liu
DMAP‐Catalyzed C—N Bond Formation for Diverse Synthesis of Imidazo[1,2‐a]pyrimidine and Pyrimido[1,2‐a]benzimidazole Derivatives
Chinese Journal of Chemistry  38(12), 1595, 2020
DOI: 10.1002/cjoc.202000214

[2]. Mudumala Veeranarayana Reddy, Kang Rok Byeon, Su Hong Park, Dong Wook Kim
Polyethylene glycol methacrylate-grafted dicationic imidazolium-based ionic liquid: Heterogeneous catalyst for the synthesis of aryl-benzo[4,5]imidazo[1,2- a ]pyrimidine amines under solvent-free conditions
Tetrahedron  73(35), 5289, 2017
DOI: 10.1016/j.tet.2017.07.025

[3]. Youness El Bakri, Chin-Hung Lai, Subramani Karthikeyan, Lei Guo, Sajjad Ahmad, Ali Ben-Yahya, Joel T. Mague, El Mokhtar Essassi
Synthesis, Crystal structure, Hirshfeld surface Analysis and computational approach of new 2-methylbenzimidazo[1,2-a]pyrimidin-4(1H)-one
Journal of Molecular Structure  1239, 130497, 2021
DOI: 10.1016/j.molstruc.2021.130497

[4]. Amol Maruti Jadhav, Yeong Il Kim, Kwon Taek Lim, Yeon Tae Jeong
Application of p -TSA in the one pot synthesis of N -methyl-3-nitro-aryl-benzo[4,5]imidazo[1,2- a ]pyrimidin-2-amine
Tetrahedron Letters  59(6), 554, 2018
DOI: 10.1016/j.tetlet.2018.01.008

[5]. V. A. Risley, S. Henry, M. V. Kosyrikhina, M. R. Manzanares, I. Payan, C. D. Downer, C. C. Hellmann, S. Van Slambrouck, L. V. Frolova
4-Amino-2-Aryl-3-Cyano-1,2-Dihydropyrimido-[1,2-a]Benzimidazoles AND their Pyrimidine Analogs as New Anticancer Agents
Chemistry of Heterocyclic Compounds  50(2), 185, 2014
DOI: 10.1007/s10593-014-1460-0

[6]. Shuai Fang, Xiaoyi Niu, Bingchuan Yang, Yanqiu Li, Xiaomeng Si, Lei Feng, Chen Ma
One-Pot Synthesis of Benzo[4,5]imidazo[1,2-a]quinazoline Derivatives via Facile Transition-Metal-Free Tandem Process
ACS Combinatorial Science  16(7), 328, 2014
DOI: 10.1021/co500001u

[7]. Ali Gumaan El-Shekeil, Abeer Omer Abubakr, Sama Abdalla Al-Aghbari, Mogahid Yahya Nassar
Anticancer 4: Anticancer and DNA cleavage studies of some new Schiff base titanium (IV) complexes
European Journal of Chemistry  5(3), 410, 2014
DOI: 10.5155/eurjchem.5.3.410-414.996

[8]. Saradindu Debnath, Syaleena Parveen, Priyankar Pradhan, Ipsita Das, Tapas Das
Benzo[4,5]imidazo[1,2-a]pyridines and benzo[4,5]imidazo[1,2-a]pyrimidines: recent advancements in synthesis of two diversely important heterocyclic motifs and their derivatives
New Journal of Chemistry  46(22), 10504, 2022
DOI: 10.1039/D2NJ00546H

[9]. Dong Young Kim, Pham Duy Quang Dao, Chan Sik Cho
Synthesis of Pyrimidine- and Quinazoline-Fused Benzimidazole-4,7-diones Using Combinatorial Cyclocondensation and Oxidation
ACS Omega  3(12), 17456, 2018
DOI: 10.1021/acsomega.8b02755

[10]. Pham Duy Quang Dao, Ha Kyeong Lee, Ho-Sang Sohn, Nam Sik Yoon, Chan Sik Cho
Synthesis of Benzo[4,5]imidazo[1,2-c]pyrimidin-1-amines and Their Analogs via Copper-Catalyzed C–N Coupling and Cyclization
ACS Omega  2(6), 2953, 2017
DOI: 10.1021/acsomega.7b00693

[11]. Tariq A. Shah, Waseem Raza, M. Muneer, Niyaz A. Mir, Musheer Ahmad
Triphenylphosphine/Isocyanide Mediated Synthesis of Benzo[4,5]imidazo[1,2‐a]pyrimidine, Enamine Ketones and Secondary Ketimines
ChemistrySelect  3(3), 946, 2018
DOI: 10.1002/slct.201702724

[12]. Mengyi Guo, Xin Huang, Suzhen Li, Wanqian Ma, Aqin Liu, Xiuyu Zhang, Qiulin Kuang, Luoteng Cheng, Yibo Song, Xueyuan Hu, Jianyong Yuan
Synthesis of Substituted of Benzo[4,5]imidazo[1,2-a]pyrimidines through (3 + 2+1) Cyclization of 2-Aminobenzimidazole, Acetophenone, and N,N-Dimethylformamide as One-Carbon Synthon
The Journal of Organic Chemistry  , , 2023
DOI: 10.1021/acs.joc.3c01227


[1]. Ramla, M. M.; Omer, M. A.; El-Khamry, A. M. M.; El-Diwani, H. I. Bioorg. Med. Chem. 2006, 14, 7324-7332.

[2]. Yang, Y. H.; Cheng, M. S.; Wang, Q. H.; Nie, H.; Liao, N.; Wang, J.; Chen, H.; Design. Eur. J. Med. Chem. 2009, 44, 1808-1812.

[3]. Penning, T. D.; Zhu, G. D.; Gandhi, V. B.; Gong Thomas, S. J.; Lubisch, W.; Gradel, R.; Wernet, W.; Park, C. H.; Fry, E. H.; Liu X.; Shi, Y.; Klinghofer, V.; Johnson, E. F.; Donawho, C. K.; Frost, D. J.; Diaz, V. B.; Bouska, J. J.; Olson, A. M.; Marsh, K. C. Bioorg. Med. Chem. 2008, 16, 6965-6975.

[4]. Garuti, L.; Roberti, M.; Pizzirani, D.; Pession A.; Leoncini, E.; Cenci, V.; Hrelia, S. Il Farmaco 2004, 59, 663-668.

[5]. Spasov, A. R.; Iezhitsa, I. N.; Bugaeva, L. I.; Anisimova, V. A. Khim. Farm. Zh. 1999, 33, 6-12.

[6]. Parshanth, A.; David, W. W. J. Am. Chem. Soc. 2009, 131, 7618-7624.
PMid:19445463 PMCid:2698132

[7]. Klimesova, V.; Koci, J.; Pour, M.; Stachel, J.; Waisser, K.; Kaustova, J. Eur. J. Med. Chem. 2002, 37, 409-420.

[8]. Sondhi, S. M.; Singhal, N.; Johar, M.; Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 2002, 9, 1045-1074.

[9]. Demirayak, S.; Mohsen, U. A.; Karaburun, A. C. Eur. J. Med. Chem. 2002, 37, 225-260.

[10]. Huang, S. T.; Hsei, I. J.; Chen, C. Bioorg. Med. Chem. 2006, 14, 6106-6119.

[11]. Boiani, M.; Gonzalez, M. Mini-Rev. Med. Chem. 2005, 5, 409-424.

[12]. Hori, A.; Imaeda, Y.; Kubo, K.; Kusaka, M. Cancer lett. 2002, 183, 53-62.

[13]. Nawrocka, W; Sztuba, B.; Kowalska, M. W.; Liszkiewicz, H.; Wietrzyk, J.; Nasulewicz, A.; Pelczynska, M.; Opolski, A. Il Farmaco 2004, 59(2), 83-91.

[14]. Mosmann, T. J. Immunol. Methods 1983, 65(1-2), 55-63.

How to cite

El-Shekeil, A.; Obeid, A.; Al-Aghbari, S. Eur. J. Chem. 2012, 3(3), 356-358. doi:10.5155/eurjchem.3.3.356-358.621
El-Shekeil, A.; Obeid, A.; Al-Aghbari, S. Anticancer activity studies of some cyclic benzimidazole derivatives. Eur. J. Chem. 2012, 3(3), 356-358. doi:10.5155/eurjchem.3.3.356-358.621
El-Shekeil, A., Obeid, A., & Al-Aghbari, S. (2012). Anticancer activity studies of some cyclic benzimidazole derivatives. European Journal of Chemistry, 3(3), 356-358. doi:10.5155/eurjchem.3.3.356-358.621
El-Shekeil, Ali, Abeer Omer Obeid, & Sama Al-Aghbari. "Anticancer activity studies of some cyclic benzimidazole derivatives." European Journal of Chemistry [Online], 3.3 (2012): 356-358. Web. 10 Dec. 2023
El-Shekeil, Ali, Obeid, Abeer, AND Al-Aghbari, Sama. "Anticancer activity studies of some cyclic benzimidazole derivatives" European Journal of Chemistry [Online], Volume 3 Number 3 (30 September 2012)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item

DOI Link:

CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley

European Journal of Chemistry 2012, 3(3), 356-358 | doi: | Get rights and content


  • There are currently no refbacks.

Copyright (c)

© Copyright 2010 - 2023  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.